![Full article: Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system Full article: Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system](https://www.tandfonline.com/cms/asset/2987724f-1f39-4dbd-a16d-2cb7e362cab3/iern_a_1847645_f0002_oc.jpg)
Full article: Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system
![Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus | Circulation Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus | Circulation](https://www.ahajournals.org/cms/asset/84d8b41f-0363-4584-9bad-c45344452da5/2895fig04.gif)
Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus | Circulation
![Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats | Nature Medicine Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats | Nature Medicine](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnm.3787/MediaObjects/41591_2015_Article_BFnm3787_Fig1_HTML.jpg)
Metformin activates a duodenal Ampk–dependent pathway to lower hepatic glucose production in rats | Nature Medicine
![Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/3705bc47-7921-4c1b-8878-d96df55e3af9/gr1.gif)
Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial - The Lancet Diabetes & Endocrinology
![Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial | BMC Musculoskeletal Disorders | Full Text Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial | BMC Musculoskeletal Disorders | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12891-022-05434-2/MediaObjects/12891_2022_5434_Fig1_HTML.png)
Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial | BMC Musculoskeletal Disorders | Full Text
![Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning (Review) Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning (Review)](https://www.spandidos-publications.com/article_images/ol/11/2/ol-11-02-1287-g02.jpg)
Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning (Review)
Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomi
![Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial | BMC Endocrine Disorders | Full Text Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial | BMC Endocrine Disorders | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12902-020-00618-0/MediaObjects/12902_2020_618_Fig1_HTML.png)
Effect of metformin in addition to an antenatal diet and lifestyle intervention on fetal growth and adiposity: the GRoW randomised trial | BMC Endocrine Disorders | Full Text
![Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus | Circulation Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus | Circulation](https://www.ahajournals.org/cms/asset/c88c4efe-4e06-4f5f-8c0b-87adf5ffbb4f/2895fig05.gif)
Metformin Improves Insulin Sensitivity and Vascular Health in Youth With Type 1 Diabetes Mellitus | Circulation
![Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial | BMC Pregnancy and Childbirth | Full Text Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial | BMC Pregnancy and Childbirth | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12884-016-0954-4/MediaObjects/12884_2016_954_Fig1_HTML.gif)
Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial | BMC Pregnancy and Childbirth | Full Text
![PDF) Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial | P. Mocarelli - Academia.edu PDF) Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial | P. Mocarelli - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/92320337/mini_magick20221012-1-ojqm7v.png?1665563652)
PDF) Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial | P. Mocarelli - Academia.edu
![Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial - ScienceDirect Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0939475312002207-gr1.jpg)
Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: Impact on cardiovascular events. A randomized controlled trial - ScienceDirect
![PDF) Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 – secondary analysis of a randomized controlled trial PDF) Metformin and insulin treatment of gestational diabetes: effects on inflammatory markers and IGF-binding protein-1 – secondary analysis of a randomized controlled trial](https://i1.rgstatic.net/publication/342871313_Metformin_and_insulin_treatment_of_gestational_diabetes_effects_on_inflammatory_markers_and_IGF-binding_protein-1_-_secondary_analysis_of_a_randomized_controlled_trial/links/5fc21076a6fdcc6cc6778a41/largepreview.png)